ZIOPHARM ONCOLOGY INC (ZIOP) Stock Analyst Ratings
NASDAQ:ZIOP - Nasdaq - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to ZIOP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4. This target is 361.48% above the current price.
ZIOP was analyzed by 13 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about ZIOP.
In the previous month the buy percentage consensus was at a similar level.
ZIOP was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-09 | Raymond James | Maintains | Market Perform |
| 2021-08-10 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-05-07 | Raymond James | Maintains | Outperform |
| 2021-03-12 | Jefferies | Downgrade | Buy -> Hold |
| 2021-03-01 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |